Omega-3 polyunsaturated fatty acids/vitamin e Interactions
There are 289 drugs known to interact with omega-3 polyunsaturated fatty acids/vitamin e, along with 4 disease interactions. Of the total drug interactions, 1 is major, 190 are moderate, and 98 are minor.
- View all 289 medications that may interact with omega-3 polyunsaturated fatty acids/vitamin e
- View omega-3 polyunsaturated fatty acids/vitamin e disease interactions (4)
Most frequently checked interactions
View interaction reports for omega-3 polyunsaturated fatty acids / vitamin e and the medicines listed below.
- Acidophilus Probiotic Blend (lactobacillus acidophilus)
- Aimovig (erenumab)
- Alavert (loratadine)
- Aleve (naproxen)
- Alive Max3 Potency Men's Multivitamin (multivitamin with minerals)
- Aptiom (eslicarbazepine)
- Armour Thyroid (thyroid desiccated)
- Aspirin Low Strength (aspirin)
- Botox (onabotulinumtoxinA)
- Calcium 600 D (calcium / vitamin d)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flonase (fluticasone nasal)
- Ginkgo Biloba (ginkgo)
- Iron Sulfate (ferrous sulfate)
- Jardiance (empagliflozin)
- K2 Plus D3 (multivitamin)
- Magnesium Mineral Support (magnesium malate)
- Menopause Support (black cohosh)
- Mucinex (guaifenesin)
- NAC (acetylcysteine)
- Tylenol (acetaminophen)
- Vitamin B Complex 100 (multivitamin)
- Vitamin B1 (thiamine)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Vitamin K2 (menaquinone)
- Zinc (zinc sulfate)
- Zyrtec (cetirizine)
Omega-3 polyunsaturated fatty acids/vitamin e disease interactions
There are 4 disease interactions with omega-3 polyunsaturated fatty acids / vitamin e which include:
Report options
QR code containing a link to this page
More about omega-3 polyunsaturated fatty acids / vitamin e
- omega-3 polyunsaturated fatty acids/vitamin e consumer information
- Compare alternatives
- Side effects
- Drug class: nutraceutical products
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.